-Consecutive patients of decompensated cirrhosis of any etiology, presenting to the Institute of Liver and Biliary Sciences hospital with spontaneous bacterial peritonitis will be evaluated
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
120
GMCSF 1.5mcg/Kg
Tablet Norfloxacin 400 mg
Institute of Liver & Biliary Sciences
New Delhi, National Capital Territory of Delhi, India
Spontaneous Bacterial Peritonitis on secondary prophylaxis in both groups
Spontaneous Bacterial Peritonitis is defined as Polymorphonuclear count \> 250 in ascitic fluid
Time frame: 6 Month
Survival in both groups after development of SBP (Spontaneous Bacterial Peritonitis ).
Spontaneous Bacterial Peritonitis is defined as Polymorphonuclear count \> 250 in ascitic fluid.
Time frame: 4 weeks
Survival in both groups after development of SBP (Spontaneous Bacterial Peritonitis ).
Spontaneous Bacterial Peritonitis is defined as Polymorphonuclear count \> 250 in ascitic fluid.
Time frame: 12 weeks
Survival in both groups after development of SBP (Spontaneous Bacterial Peritonitis ).
Spontaneous Bacterial Peritonitis is defined as Polymorphonuclear count \> 250 in ascitic fluid.
Time frame: 24 weeks
Survival in both groups after development of SBP (Spontaneous Bacterial Peritonitis ).
Spontaneous Bacterial Peritonitis is defined as Polymorphonuclear count \> 250 in ascitic fluid.
Time frame: 48 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.